Inhibition of LYPD1 is critical for endothelial network formation in bioengineered tissue with human cardiac fibroblasts
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 166, 109-121
Abstract
No abstract availableKeywords
Funding Information
- Mochida Memorial Foundation for Medical and Pharmaceutical Research (JP17bm0404015, 16K15449)
- Takeda Science Foundation (JP17bm0404015, 16K15449)
- Japan Agency for Medical Research and Development (JP17bm0404015, 16K15449)
- Japan Society for the Promotion of Science (JP17bm0404015, 16K15449)
This publication has 41 references indexed in Scilit:
- A role for LYNX2 in anxiety-related behaviorProceedings of the National Academy of Sciences, 2009
- Cardiac Fibroblasts Regulate Myocardial Proliferation through β1 Integrin SignalingDevelopmental Cell, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2008
- Cardiac fibroblasts influence cardiomyocyte phenotype in vitroAmerican Journal of Physiology-Cell Physiology, 2007
- Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potentialBiochemical and Biophysical Research Communications, 2006
- Identification of lynx2, a novel member of the ly-6/neurotoxin superfamily, expressed in neuronal subpopulations during mouse developmentMolecular and Cellular Neuroscience, 2006
- Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblastsCardiovascular Research, 1998
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994